Synergen Met's Managing Director, Chris Dunks discusses PFAS and companies' role in destroying the chemical.
Synergen Met Ltd (ASX:SH2) is seeking to raise A$25m at an issue price of $0.20 per share, together with two (2) free attaching Options for every four (4) Shares subscribed for and issued (Public Offer).
Learn more: https://www.barclaypearce.com.au/blog/synergen-met-ltd-ipo-live-now-register-your-interest
---------------------------
Disclaimer:
Barclay Pearce Capital Pty Ltd is a Corporate Authorised Representative (Authorisation Number: 1277964) of Barclay Pearce Capital Management Pty Ltd, the holder of an Australian Financial Services Licence (Number: 503261).
This podcast is for information purposes only and should not be construed as an offer or solicitation or recommendation to buy or sell financial products. The information contained in this podcast is directed and available to residents of Australia only. The distribution of information to persons outside this criteria may be restricted by law and persons who come into possession of it should seek advice and observe any such restriction.
The information provided in this podcast is general in nature only and does not constitute personal advice. The information has been prepared without taking into account you or your company’s objectives, financial situation or needs. Before acting on any information in this podcast you should consider the appropriateness of the information having regard to your objectives, financial situation and needs. You should seek independent financial advice and read the relevant disclosure statements or other offer documents prior to making an investment decision about a financial product.
Synergen Met's Managing Director, Chris Dunks discusses PFAS and companies' role in destroying the chemical.
Synergen Met Ltd (ASX:SH2) is seeking to raise A$25m at an issue price of $0.20 per share, together with two (2) free attaching Options for every four (4) Shares subscribed for and issued (Public Offer).
Learn more: https://www.barclaypearce.com.au/blog/synergen-met-ltd-ipo-live-now-register-your-interest
---------------------------
Disclaimer:
Barclay Pearce Capital Pty Ltd is a Corporate Authorised Representative (Authorisation Number: 1277964) of Barclay Pearce Capital Management Pty Ltd, the holder of an Australian Financial Services Licence (Number: 503261).
This podcast is for information purposes only and should not be construed as an offer or solicitation or recommendation to buy or sell financial products. The information contained in this podcast is directed and available to residents of Australia only. The distribution of information to persons outside this criteria may be restricted by law and persons who come into possession of it should seek advice and observe any such restriction.
The information provided in this podcast is general in nature only and does not constitute personal advice. The information has been prepared without taking into account you or your company’s objectives, financial situation or needs. Before acting on any information in this podcast you should consider the appropriateness of the information having regard to your objectives, financial situation and needs. You should seek independent financial advice and read the relevant disclosure statements or other offer documents prior to making an investment decision about a financial product.